跳至主要内容
临床试验/IRCT20170202032367N9
IRCT20170202032367N9尚未招募3 期

The effects of melatonin supplementation on oxidative stress, inflammatory biomarkers and lipid profile in diabetic patients with chronic kidney disease- a randomized trial

Tehran University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 65 years(—)
性别
All

入选标准

  • Age above 25 and below 65 years
  • Having CKD in the stage before dialysis (stage 3 to 4) which is diagnosed based on laboratory findings and the opinion of a nephrologist.
  • Body mass index above 20 and below 30 kg/m2
  • Willingness to cooperate in this study

排除标准

  • Having CKD due to autoimmune diseases and glomerulonephritis
  • Blood pressure higher than 100/160 mmHg
  • Pregnancy or intention to become pregnant within the next 6 months, breastfeeding
  • Infectious, inflammatory diseases, thyroid gland disorders, thrombocytopenia
  • Being under enteral and parenteral nutritional support
  • Taking omega-3 supplements and antioxidant supplements (vitamin E, vitamin C, vitamin B6, selenium, zinc and beta-carotene separately) from 3 months before entering the study
  • Taking glucocorticoid drugs with a dose of more than 5 mg, antibiotics, fluoxamin, non-steroidal anti-inflammatory drugs, warfarin
  • People who have night shift jobs

研究者

相似试验

The effects of melatonin supplementation on... | 临床试验